Rosa M Giraldez-Perez | Intracellular Transport Systems | Innovative Research Award

Prof. Dr. Rosa M Giraldez-Perez | Intracellular Transport Systems | Innovative Research Award

University or Cordoba | Spain

Rosa María Giráldez-Pérez is a researcher in the fields of nanotechnology, nanomedicine, physiology, and neuroscience whose scientific contributions focus on the design and application of nanomaterials for therapeutic purposes. Her work has addressed innovative strategies such as gold nanosystems functionalized with antibiotics or anticancer drugs, the development of nanocarriers for leukemia, prostate, liver, and lung cancer treatments, as well as nanoparticle-based approaches to prevent antibiotic resistance. She has also contributed to research in obesity therapy through nanosystems targeting metabolic regulation and in neuroscience through studies on oxidative stress and fragile X syndrome. Her research output includes 81 scientific documents, which have accumulated 911 citations and reflect an h-index of 13, demonstrating both productivity and impact in her field. A significant portion of her publications are in high-impact journals indexed in the Journal Citation Reports (JCR), and several list her as first or senior author, highlighting her leading role in collaborative projects. By integrating expertise from cellular biology, physiology, and nanoscience, her work advances translational biomedical research and offers potential therapeutic solutions for cancer, infectious diseases, metabolic disorders, and neurological conditions.

Profiles: Orcid | Scopus

Featured Publications:

Giráldez-Pérez, R. M., Grueso, E. M., Montero-Hidalgo, A. J., Muriana-Fernández, C., Kuliszewska, E., Luque, R. M., & Prado-Gotor, R. (2025). Daunomycin nanocarriers with high therapeutic payload for the treatment of childhood leukemia. Pharmaceutics, 17(9), 1236.

De Diego-Otero, Y., El Bekay, R., García-Guirado, F., Sánchez-Salido, L., & Giráldez-Pérez, R. M. (2024). Apocynin, a selective NADPH oxidase (Nox2) inhibitor, ameliorates behavioural and learning deficits in the fragile X syndrome mouse model. Biomedicines, 12(2887).

Lhamyani, S., Gentile, A. M., Mengual-Mesa, M., Grueso, E., Giráldez-Pérez, R. M., Fernandez-Garcia, J. C., … El Bekay, R. (2024). Au@16-pH-16/miR-21 mimic nanosystem: An efficient treatment for obesity through browning and thermogenesis induction. Biomedicine & Pharmacotherapy, 171, 116104.

Giráldez-Pérez, R. M., Grueso-Molina, E. M., Carbonero-Martínez, A., Álvarezmárquez, J., Kuliszewska, E., Gordillo-Macías, M., & Prado-Gotor, R. (2023). Synergistic antibacterial effects of amoxicillin and gold nanoparticles: A therapeutic option to combat antibiotic resistance. Antibiotics, 12(8), 81275.

Giráldez-Pérez, R. M., Grueso, E., Montero-Hidalgo, A. J., Luque, R. M., Carnerero, J. M., Kuliszewska, E., & Prado-Gotor, R. (2022). Gold nanosystems covered with doxorubicin/DNA complexes: A therapeutic target for prostate and liver cancer. International Journal of Molecular Sciences, 23(24), 15575.

Giráldez-Pérez, R. M., Grueso, E. M., Jiménez-Aguayo, R., Carbonero, A., González-Bravo, M., Kuliszewska, E., & Prado-Gotor, R. (2022). Use of nanoparticles to prevent resistance to antibiotics: Synthesis and characterization of gold nanosystems based on tetracycline. Pharmaceutics, 14(9), 1941.

Lhamyani, S., Gentile, A. M., Giráldez-Pérez, R. M., et al. (2021). miR-21 mimic blocks obesity in mice: A novel therapeutic option. Molecular Therapy – Nucleic Acids, 26, 401–416. h

Grueso-Molina, E. M., Giráldez-Pérez, R. M., Kuliszewska, E., Guerrero, J. A., & Prado-Gotor, R. (2021). Reversible cationic gemini surfactant-induced aggregation of anionic gold nanoparticles for sensing biomolecules. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 610, 125893.

Gomes, A., Carnerero-Panduro, J. M., Jiménez-Ruiz, A., Grueso-Molina, E. M., Giráldez-Pérez, R. M., & Prado-Gotor, R. (2021). Lysozyme-AuNPs interactions: Determination of binding free energy. Nanomaterials, 11(8), 2139.

Giráldez-Pérez, R. M., Grueso-Molina, E. M., Domínguez-García, I., Pastor-Carrillo, N. M., Kuliszewska, E., & Prado-Gotor, R. (2021). Biocompatible DNA/5-fluorouracil gemini surfactant-functionalized gold nanoparticles as promising vectors in lung cancer therapy. Pharmaceutics, 13(3), 423.

Abdolraouf Samadi-Maybodi | Molecular Mechanisms Signaling | Best Researcher Award

Prof. Abdolraouf Samadi-Maybodi | Molecular Mechanisms Signaling | Best Researcher Award

Prof. Abdolraouf Samadi-Maybodi | University of Mazandaran | Iran

Dr. Abdolraouf Samadi-Maybodi is a distinguished Iranian chemist and professor at the University of Mazandaran, Babolsar, Iran. He has played a pivotal role in advancing the field of inorganic and analytical chemistry, particularly through his work in NMR spectroscopy, zeolite synthesis, and nanomaterials. Over a career spanning more than three decades, Dr. Samadi-Maybodi has held various academic positions including Assistant Professor, Associate Professor, and Professor. He has published over 107 research papers in peer-reviewed journals and actively collaborates with international scholars. A member of prestigious societies like the American Chemical Society (ACS), Royal Society of Chemistry (RSC), and Iranian Society of Chemistry, he is recognized for his interdisciplinary contributions that bridge classical chemistry with modern nanotechnology. His leadership roles include serving as Department Head and Research Manager, making him a strong candidate for a Best Researcher Award.

Publication Profile: 

Google Scholar

Education:

Dr. Samadi-Maybodi earned his Ph.D. in Chemistry from the University of Durham, U.K., where he conducted pioneering work on NMR studies of silicate and aluminosilicate solutions under the supervision of Prof. Robin K. Harris. His doctoral thesis, titled “NMR Studies of Silicate and Aluminosilicate Solutions as Precursors for Zeolites,” laid the foundation for much of his later work in zeolite synthesis and spectroscopy. He previously obtained his M.Sc. in Analytical Chemistry  from the University of Mazandaran, Iran, where he explored chemiluminescence of peroxyoxalates under the guidance of Prof. M.R. Hadjmohammadi. His B.Sc. in Chemistry was completed at Shahid Beheshti University, Tehran. This strong academic foundation in both theoretical and applied chemistry has allowed him to integrate classical analytical techniques with modern materials science in his subsequent research.

Experience:

Dr. Samadi-Maybodi has accumulated vast academic experience over nearly four decades. He began his career as a teaching assistant in analytical and instrumental analysis at the University of Mazandaran. He pursued his Ph.D. studies in the UK, followed by a faculty appointment upon his return. His roles at the university include Assistant Professor, Associate Professor, and full Professor from 2008 onwards. He has taught courses across all academic levels, including Advanced NMR Spectroscopy, Thermal Analysis, and Spectroscopic Techniques. His leadership experience includes being Head of the Chemistry Department and Research Manager. He also completed a sabbatical at the University of Western Ontario, Canada. His dedication to teaching, research, and university management demonstrates his holistic contribution to academic science in Iran and abroad.

Research Focus:

Dr. Samadi-Maybodi’s research is deeply rooted in physical and analytical chemistry, with a specialized focus on Nuclear Magnetic Resonance (NMR) spectroscopy for studying silicate and aluminosilicate systems. He is renowned for applying advanced spectroscopic techniques to investigate zeolite formation mechanisms, chemical structures, and solution dynamics. His interest in nanomaterials has led to significant contributions in quantum dots, fluorescence spectroscopy, and photocatalysis. More recently, his work has expanded into environmental chemistry, particularly in the development of novel nanostructured materials for water treatment and pesticide removal. His interdisciplinary approach bridges traditional analytical methods with cutting-edge materials science, resulting in applications across catalysis, environmental cleanup, and energy systems. With over 100 publications, Dr. Samadi-Maybodi continues to make impactful contributions to both fundamental science and applied technologies, maintaining active collaborations with leading researchers worldwide.

Publications Top Notes: 

  1. A new silicate clathrate hydrate: X-ray and NMR study with octameric silicate anions – JSSC

  2. Exchange reactions in aluminosilicate solutions – Chem. Comm.

  3. XRD and NMR study of silicate with nitrogenous cations – Dalton Trans.,

  4. Aluminum incorporation into silicates via 27Al NMR – Zeolites

  5. Discovery of a novel symmetric silicate anion – Dalton Trans.

  6. New oscillating chemiluminescence system with tetraalkylammonium hydroxide – ISBC

  7. Highly resolved 27Al NMR of aluminosilicates – Dalton Trans.

  8. 29Si NMR of methoxysilicic acid in silicate solutions – Mag. Res. Chem.

  9. 29Si DOSY NMR for aqueous silicate studies – Chem. Comm.

  10. Headspace analysis of male/female kiwifruit flowers – J. Essential Oil Res.

Conclusion:

Prof. Abdolraouf Samadi-Maybodi’s research legacy is a testament to decades of scientific dedication, innovation, and academic leadership. His deep-rooted expertise in NMR spectroscopy, silicate chemistry, nanomaterials, and environmental chemistry places him among the leading researchers in his field, especially in Iran and the broader Middle East. His sustained scholarly output, collaborative international engagements, and mentorship of numerous students make him a strong candidate for the Best Researcher Award. With a solid academic foundation, impactful research, and proven administrative skills, Prof. Samadi-Maybodi exemplifies the qualities of a well-rounded and deserving researcher. Recognizing him with this award would not only honor his past contributions but also motivate continued excellence and inspire others in the scientific community.

Sibel Elif Gultekin | Stem Cell Research | Best Researcher Award

Prof. Dr. Sibel Elif Gultekin | Stem Cell Research | Best Researcher Award

Prof. Dr. Sibel Elif Gultekin, Gazi University Faculty of Dentistry, Turkey

Prof. Dr. Sibel Elif Gültekin is a renowned academic and clinician in Oral Pathology and Periodontology at Gazi University Faculty of Dentistry, Türkiye. With over two decades of experience, she has significantly advanced molecular understanding of odontogenic tumors, HPV-induced oral lesions, and periodontal regeneration. Holding both DDS and Ph.D. degrees, she has led her department as Chair for 10 years and contributed globally as a visiting researcher and advisor. Her collaborations with institutions like the University of Cologne and UCSF reflect her international impact. She has published extensively in high-impact journals, authored books, and mentored numerous young researchers. Her dedication has been recognized through editorial appointments and professional society memberships. Prof. Gültekin’s translational research bridges pathology and clinical dentistry, making her a pioneer in the diagnosis and treatment of oral diseases.

Publication Profile: 

Orcid

✅ Strengths for the Award:

  1. Dual Specialization & Academic Leadership: Prof. Gültekin’s rare dual Ph.D. in Oral Pathology and Periodontology, along with her decade-long leadership as department chair, highlights deep academic and organizational expertise.

  2. High Research Output & Impact: With 96 publications, 50+ research projects, and citations exceeding 1300 (Google Scholar), her scholarly productivity and influence are clear. Her h-index across databases (14–17) confirms consistent academic contribution.

  3. Global Collaborations: Active collaborations with international centers like UCSF and University of Cologne underscore her role in global scientific advancement.

  4. Innovative Research Areas: She works at the forefront of molecular oncology, focusing on HPV-associated oral cancers, odontogenic tumors, and biomarkers like P16, VIM3, and PDCD4.

  5. Educational & Editorial Leadership: Served on scientific and editorial boards, symposiums, and advisory panels; she also authored 2 academic books and guided national congresses.

  6. Professional Societies: Active member of multiple esteemed societies (IAOP, ESP, EHNS, IADR), reflecting recognition in the international scientific community.

⚙️ Areas for Improvement:

  1. Clinical Translation Scaling: While her biomarker discoveries are notable, increasing efforts to lead translational clinical trials could accelerate therapeutic application.

  2. Policy Advocacy: Engaging more in international oral health policy or WHO-affiliated programs could amplify her impact beyond academia.

  3. Mentorship on Global Scale: Expanding formal international mentorship programs or fellowships could further cement her influence and legacy.

🎓 Education:

Prof. Dr. Sibel Elif Gültekin holds both DDS and Ph.D. degrees, specializing in Oral Pathology and Periodontology. She completed her undergraduate dental studies at Gazi University Faculty of Dentistry, where she later pursued her doctoral studies. Her academic training extended beyond Türkiye through international fellowships and research placements, including the prestigious Department of Medicine and Stomatology at the University of California San Francisco (UCSF) and the Institute for Pathology at the University of Cologne. Her educational journey is marked by an interdisciplinary approach, blending basic sciences and clinical applications. These robust academic foundations have positioned her as a global expert in oral cancer biomarkers, regenerative periodontology, and molecular pathology, nurturing future dentists and researchers through an integrative, evidence-based curriculum and global research exposure.

💼 Experience:

Prof. Dr. Gültekin has over 25 years of experience in dentistry, oral pathology, and periodontology. She has served as Professor and Chair of the Department of Oral Pathology at Gazi University, shaping both academic curricula and national diagnostic standards. Internationally, she collaborated with UCSF and the University of Cologne on pioneering projects in oral cancer and HPV research. Her clinical and academic background spans over 50 funded research projects, with 96 published papers in prestigious journals indexed by SCI, Scopus, and PubMed. She has contributed to oral health policy through editorial and advisory roles, including at journals like Journal of Oral Health Frontiers. Her expertise has guided scientific boards and symposia in Türkiye and beyond, particularly in head and neck pathology. She remains a sought-after consultant and reviewer, advocating for personalized medicine and molecular diagnostics in oral health.

🔬 Research Focus:

Prof. Dr. Sibel Elif Gültekin’s research centers on the molecular mechanisms of oral diseases, particularly odontogenic tumors, oral epithelial dysplasia, and HPV-induced carcinomas. She has made key contributions in identifying biomarkers such as P16, PDCD4, VIM3, and CD8+ T-cell infiltrates, enhancing early diagnosis and prognosis of oral and oropharyngeal cancers. Her research also explores microsatellite instability and loss of heterozygosity in oral squamous cell carcinoma. Additionally, she has contributed to periodontal tissue regeneration studies and the development of personalized therapeutic strategies. With over 1,300 citations and an h-index of 17 on Google Scholar, her impactful work bridges molecular science and clinical application. Collaborating with global experts in pathology, oncology, and molecular biology, Prof. Gültekin’s research not only contributes to academic literature but also informs clinical protocols and treatment pathways in modern dentistry and oral oncology.

📚 Publications Top Notes:

  • 🧬 Microsatellite Instability and Loss of Heterozygosity as Prognostic Markers in Oral Squamous Cell Carcinoma (Genes, Chromosomes and Cancer, 2024)

  • 🧪 Efficiency of B-RAF-/MEK-inhibitors in B-RAF Mutated Ameloblastoma: Case Report and Review (Heliyon, 2023)

  • 🦷 Kişiselleştirilmiş Diş Hekimliği (ADO Klinik Bilimler Dergisi, 2023)

  • 🔍 Apoptosis Related PDCD4: Promising Novel Biomarker for Early Detection of Oral Cancer (ADO Klinik Bilimler Dergisi, 2022)

  • 🛡️ PD-L1 Expression and High CD8+ Lymphocyte Infiltrate Predict Outcome in Oropharyngeal SCC (International Journal of Molecular Sciences, 2020)

🧾 Conclusion:

Prof. Dr. Sibel Elif Gültekin is a highly deserving nominee for the Best Researcher Award. Her pioneering contributions in oral pathology, particularly in molecular diagnostics and HPV-related oral oncology, place her at the forefront of dental research. Her exceptional academic record, leadership, and dedication to collaborative and translational science make her a standout candidate who embodies the spirit of innovation, mentorship, and global impact.